Top compounds associated with response to PRR29


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA Parthenolide CTRPv2 pan-cancer AAC -0.016 0.7
mRNA PF-543 CTRPv2 pan-cancer AAC 0.016 0.7
mRNA skepinone-L CTRPv2 pan-cancer AAC 0.022 0.7
mRNA Sorafenib CCLE pan-cancer AAC -0.018 0.7
mRNA Axitinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.022 0.7
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA CP466722 GDSC1000 pan-cancer AAC 0.011 0.7
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.016 0.7
Download CSV